• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然环糊精及其羟丙基化衍生物与卡马西平在水溶液中的相互作用。包合物和聚集体形成的评估。

Interaction of Native Cyclodextrins and Their Hydroxypropylated Derivatives with Carbamazepine in Aqueous Solution. Evaluation of Inclusion Complexes and Aggregates Formation.

作者信息

Rodrigues Sá Couto André, Ryzhakov Alexey, Larsen Kim Lambertsen, Loftsson Thorsteinn

机构信息

Faculty of Pharmaceutical Sciences, University of Iceland, Hofsvallagata 53, IS-107 Reykjavik, Iceland.

Department of Chemistry and Bioscience, Aalborg University, Frederik Bajers Vej 7H, DK-9220 Aalborg, Denmark.

出版信息

ACS Omega. 2019 Jan 16;4(1):1460-1469. doi: 10.1021/acsomega.8b02045. eCollection 2019 Jan 31.

DOI:10.1021/acsomega.8b02045
PMID:31459413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6648831/
Abstract

A detailed comprehensive study on how the formation of soluble and insoluble carbamazepine/cyclodextrins (CBZ/CD) complexes (with consequent changes in the solid-phase composition) depends on the CD structure is not yet available. Moreover, the study of possible influence of this drug on the tendency of CDs and their complexes to self-aggregate is still lacking. Phase-solubility studies demonstrated that CDs and CBZ form a range of soluble (A-type: αCD, βCD, and hydroxypropylated CDs) and insoluble (B-type: γCD) complexes depending on CD used. HPβCD proved to be the best CD solubilizer for CBZ forming the most stable complex with highest apparent solubility, whereas γCD was shown to be the best native CD. For the native CDs, CBZ solubilization increases with increasing CD cavity diameter (αCD ≪ βCD < γCD). Solid phases collected from phase-solubility studies were characterized by Fourier-transformed infrared spectroscopy, differential scanning calorimetry, and X-ray powder diffraction to elucidate their composition and crystalline structure. They provided similar conclusions being overall supportive of phase-solubility, osmolality, and permeation studies results. Solid CBZ was the only detected component for A-type profiles over the CD concentration range studied, whereas precipitation of poorly soluble CBZ/γCD complexes (B-type) was observed (i.e., at and beyond plateau region). Osmometry and permeation studies were applied to evaluate the effect of CBZ on the aggregate formation and also to elucidate their influence on CD complex solubility and permeation profile. Permeation method was shown to be the most effective method to detect and evaluate aggregate formation in aqueous γCD and HPβCD solutions containing CBZ. CBZ did not affect the HPβCD tendency to self-aggregate but CBZ did modify the aggregation behavior of γCD decreasing the apparent critical aggregation concentration value from 4.2% (w/v) (in pure aqueous γCD solution) to 2.5% (w/v) (when CBZ was present).

摘要

关于可溶性和不溶性卡马西平/环糊精(CBZ/CD)复合物的形成(以及随之而来的固相成变化)如何依赖于CD结构的详细全面研究尚未开展。此外,关于这种药物对CD及其复合物自聚集倾向可能产生的影响的研究仍然缺乏。相溶解度研究表明,根据所使用的CD不同,CD与CBZ会形成一系列可溶性(A型:αCD、βCD和羟丙基化CD)和不溶性(B型:γCD)复合物。HPβCD被证明是CBZ的最佳CD增溶剂,能形成最稳定的复合物且具有最高的表观溶解度,而γCD被证明是最佳的天然CD。对于天然CD,CBZ的增溶作用随着CD腔径的增大而增强(αCD≪βCD<γCD)。通过傅里叶变换红外光谱、差示扫描量热法和X射线粉末衍射对相溶解度研究中收集的固相进行表征,以阐明其组成和晶体结构。它们得出了相似的结论,总体上支持相溶解度、渗透压和渗透研究结果。在所研究的CD浓度范围内,对于A型曲线,唯一检测到的成分是固体CBZ,而观察到了难溶性CBZ/γCD复合物(B型)的沉淀(即在平台区及之后)。渗透压和渗透研究用于评估CBZ对聚集体形成的影响,并阐明其对CD复合物溶解度和渗透曲线的影响。渗透法被证明是检测和评估含CBZ的γCD和HPβCD水溶液中聚集体形成的最有效方法。CBZ不影响HPβCD的自聚集倾向,但CBZ确实改变了γCD的聚集行为,将表观临界聚集浓度值从4.2%(w/v)(在纯γCD水溶液中)降低到2.5%(w/v)(当存在CBZ时)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/c12fc6d16906/ao-2018-02045w_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/a951e8c5d52e/ao-2018-02045w_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/9df2239daceb/ao-2018-02045w_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/dc4a26519042/ao-2018-02045w_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/85d70fda9794/ao-2018-02045w_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/16e724a83bc5/ao-2018-02045w_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/ec6719565a88/ao-2018-02045w_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/1e1894ecf166/ao-2018-02045w_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/5e852e0e5ded/ao-2018-02045w_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/f82963948865/ao-2018-02045w_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/c12fc6d16906/ao-2018-02045w_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/a951e8c5d52e/ao-2018-02045w_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/9df2239daceb/ao-2018-02045w_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/dc4a26519042/ao-2018-02045w_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/85d70fda9794/ao-2018-02045w_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/16e724a83bc5/ao-2018-02045w_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/ec6719565a88/ao-2018-02045w_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/1e1894ecf166/ao-2018-02045w_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/5e852e0e5ded/ao-2018-02045w_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/f82963948865/ao-2018-02045w_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8873/6648831/c12fc6d16906/ao-2018-02045w_0002.jpg

相似文献

1
Interaction of Native Cyclodextrins and Their Hydroxypropylated Derivatives with Carbamazepine in Aqueous Solution. Evaluation of Inclusion Complexes and Aggregates Formation.天然环糊精及其羟丙基化衍生物与卡马西平在水溶液中的相互作用。包合物和聚集体形成的评估。
ACS Omega. 2019 Jan 16;4(1):1460-1469. doi: 10.1021/acsomega.8b02045. eCollection 2019 Jan 31.
2
Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.环糊精配合物的自组装:氢化可的松/环糊精配合物的聚集。
Int J Pharm. 2011 Apr 4;407(1-2):174-83. doi: 10.1016/j.ijpharm.2011.01.011. Epub 2011 Jan 13.
3
Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.基于环糊精的水合环孢素 A 滴眼剂制剂的开发。
Int J Pharm. 2015 Sep 30;493(1-2):86-95. doi: 10.1016/j.ijpharm.2015.07.040. Epub 2015 Jul 26.
4
yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.yCD/HPyCD 混合物作为增溶剂:固态特征描述和样品地塞米松滴眼混悬液。
J Pharm Pharm Sci. 2010;13(3):336-50. doi: 10.18433/j3m88b.
5
Antifungal activity of econazole nitrate/cyclodextrin complex: Effect of pH and formation of complex aggregates.硝酸益康唑/环糊精包合物的抗真菌活性:pH 值的影响及包合物聚集态的形成。
Int J Pharm. 2020 Jan 25;574:118896. doi: 10.1016/j.ijpharm.2019.118896. Epub 2019 Nov 22.
6
Characterization of the Dissolution Behavior of Piperine/Cyclodextrins Inclusion Complexes.胡椒碱/环糊精包合物溶解行为的特性研究。
AAPS PharmSciTech. 2018 Feb;19(2):923-933. doi: 10.1208/s12249-017-0908-9. Epub 2017 Oct 25.
7
The self-assemble of natural cyclodextrins in aqueous solutions: Application of miniature permeation studies for critical aggregation concentration (cac) determinations.天然环糊精在水溶液中的自组装:微型渗透研究在临界聚集浓度(cac)测定中的应用。
Int J Pharm. 2016 May 30;505(1-2):187-93. doi: 10.1016/j.ijpharm.2016.03.049. Epub 2016 Mar 25.
8
Inclusion Complexes of Rifampicin with Native and Derivatized Cyclodextrins: Modeling, Formulation, and Characterization.利福平与天然及衍生化环糊精的包合物:建模、制剂与表征
Pharmaceuticals (Basel). 2021 Dec 24;15(1):20. doi: 10.3390/ph15010020.
9
Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.环糊精-泊洛沙姆聚集体作为滴眼剂配方中的纳米载体:地塞米松和两性霉素B。
Drug Dev Ind Pharm. 2016 Sep;42(9):1446-54. doi: 10.3109/03639045.2016.1141932. Epub 2016 Feb 16.
10
A New Approach for Quantitative Determination of γ-Cyclodextrin in Aqueous Solutions: Application in Aggregate Determinations and Solubility in Hydrocortisone/γ-Cyclodextrin Inclusion Complex.水溶液中γ-环糊精定量测定的新方法:在氢化可的松/γ-环糊精包合物聚集体测定及溶解度中的应用
J Pharm Sci. 2015 Nov;104(11):3925-3933. doi: 10.1002/jps.24608. Epub 2015 Aug 6.

引用本文的文献

1
Enhancing ketoprofen's solubility and anti-inflammatory efficacy with safe methyl-β-cyclodextrin complexation.用安全的甲基-β-环糊精包合物提高酮洛芬的溶解度和抗炎疗效。
Sci Rep. 2024 Sep 14;14(1):21516. doi: 10.1038/s41598-024-71615-9.
2
Cross-Linked Thiolated Hydroxypropil-β-Cyclodextrin for Pulmonary Drug Delivery.巯基化羟丙基-β-环糊精用于肺部药物传递。
Int J Mol Sci. 2024 Aug 29;25(17):9394. doi: 10.3390/ijms25179394.
3
Copper (II) Species with Improved Anti-Melanoma and Antibacterial Activity by Inclusion in β-Cyclodextrin.

本文引用的文献

1
2-Hydroxypropyl-β-Cyclodextrin Aggregates: Identification and Development of Analytical Techniques.2-羟丙基-β-环糊精聚集体:分析技术的鉴定与发展
Materials (Basel). 2018 Oct 13;11(10):1971. doi: 10.3390/ma11101971.
2
Self-Assembly of α-Cyclodextrin and β-Cyclodextrin: Identification and Development of Analytical Techniques.α-环糊精和β-环糊精的自组装:分析技术的鉴定和发展。
J Pharm Sci. 2018 Aug;107(8):2208-2215. doi: 10.1016/j.xphs.2018.03.028. Epub 2018 Apr 7.
3
Cyclodextrins: structure, physicochemical properties and pharmaceutical applications.
β-环糊精包合提高铜(II)物种的抗黑色素瘤和抗菌活性。
Int J Mol Sci. 2023 Jan 31;24(3):2688. doi: 10.3390/ijms24032688.
4
Cyclodextrin Derivatives as Promising Solubilizers to Enhance the Biological Activity of Rosmarinic Acid.环糊精衍生物作为有前景的增溶剂以增强迷迭香酸的生物活性。
Pharmaceutics. 2022 Sep 30;14(10):2098. doi: 10.3390/pharmaceutics14102098.
5
Peptide Gelators to Template Inorganic Nanoparticle Formation.用于模板无机纳米颗粒形成的肽类凝胶剂。
Gels. 2021 Feb 2;7(1):14. doi: 10.3390/gels7010014.
6
Improvement of the Solubility and Evaluation of the Physical Properties of an Inclusion Complex Formed by a New Ferulic Acid Derivative and γ-Cyclodextrin.一种新型阿魏酸衍生物与γ-环糊精形成的包合物的溶解度改善及物理性质评价
ACS Omega. 2020 May 18;5(21):12073-12080. doi: 10.1021/acsomega.0c00277. eCollection 2020 Jun 2.
环糊精:结构、物理化学性质及药物应用。
Int J Pharm. 2018 Jan 15;535(1-2):272-284. doi: 10.1016/j.ijpharm.2017.11.018. Epub 2017 Nov 11.
4
The impact of guest compounds on cyclodextrin aggregation behavior: A series of structurally related parabens.客体化合物对环糊精聚集行为的影响:一系列结构相关的对羟基苯甲酸酯。
Int J Pharm. 2017 Aug 30;529(1-2):442-450. doi: 10.1016/j.ijpharm.2017.07.026. Epub 2017 Jul 10.
5
Self-Assembly of Cyclodextrins and Their Complexes in Aqueous Solutions.环糊精及其配合物在水溶液中的自组装
J Pharm Sci. 2016 Sep;105(9):2556-2569. doi: 10.1016/j.xphs.2016.01.019. Epub 2016 Mar 12.
6
Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-β-cyclodextrin.亲水性聚合物对卡马西平与羟丙基-β-环糊精络合作用的影响。
Eur J Pharm Sci. 2015 Oct 12;78:273-85. doi: 10.1016/j.ejps.2015.08.001. Epub 2015 Aug 6.
7
Review: a history of cyclodextrins.综述:环糊精的历史
Chem Rev. 2014 Nov 12;114(21):10940-75. doi: 10.1021/cr500081p. Epub 2014 Sep 23.
8
Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.磺丁基醚-β-环糊精(SBE-β-CD)包合物的制备、表征、分子模拟及体内抗癫痫活性评价。
AAPS PharmSciTech. 2011 Dec;12(4):1163-75. doi: 10.1208/s12249-011-9685-z. Epub 2011 Sep 15.
9
In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.新型速释卡马西平片的体外和体内评价:在 HPMC 存在下与羟丙基-β-环糊精的络合作用。
Int J Pharm. 2011 May 16;409(1-2):75-80. doi: 10.1016/j.ijpharm.2011.02.042. Epub 2011 Mar 1.
10
Cyclodextrins as pharmaceutical solubilizers.环糊精作为药物增溶剂
Adv Drug Deliv Rev. 2007 Jul 30;59(7):645-66. doi: 10.1016/j.addr.2007.05.012. Epub 2007 May 29.